Currently accepted at: JMIR Pediatrics and Parenting
Date Submitted: Oct 28, 2025
Date Accepted: Mar 4, 2026
This paper has been accepted and is currently in production.
It will appear shortly on 10.2196/86616
The final accepted version (not copyedited yet) is in this tab.
Supporting Parents of Young Children with Type 1 Diabetes Through Telehealth: A Randomized Trial of the REDCHiP Intervention
ABSTRACT
Background:
Parents of young children with type 1 diabetes (T1D) are vulnerable to experiencing hypoglycemia fear (FH), an emotional condition that includes persistent and intense worry about hypoglycemia and/or use of unhealthful behaviors to avoid hypoglycemia. Despite greater uptake of continuous glucose monitors and automated insulin delivery systems, FH remains prevalent and under-addressed in parents of young children. As such, we developed REDCHiP (Reducing Emotional Distress for Childhood Hypoglycemia in Parents), a video-based telehealth intervention designed to reduce FH in parents by providing diabetes education and teaching parents how to apply evidence-based strategies from cognitive behavioral therapy and behavior parent training in their child’s daily T1D care.
Objective:
To compare our REDCHiP intervention to a novel attention control condition (ATTN) to better isolate treatment effects for REDCHiP based on parents’ FH and diabetes distress.
Methods:
This was a multi-site randomized controlled trial. We enrolled 197 families and randomized 183 to either REDCHiP or ATTN. Both REDCHiP and ATTN parents completed 10 video-based telehealth sessions. Our primary outcomes were changes in parental FH and diabetes distress; secondary outcomes included changes in children’s glycated hemoglobin (HbA1c). We used a series of mixed effects models and logistic regression to evaluate treatment effects.
Results:
Parents in both arms attended >95% of sessions with high treatment fidelity. FH and diabetes distress decreased significantly over time across both groups. Treatment-slope effects slightly favored REDCHiP but were not statistically significant for FH (p=0.094) or distress (p=0.06). However, parents receiving REDCHiP were significantly less likely to report clinically elevated diabetes distress over time compared to ATTN (p=0.02). Child HbA1c showed a small, non-significant reduction over time (p=0.06). Parents with elevated depressive symptoms consistently reported higher FH and distress across all time points.
Conclusions:
REDCHiP demonstrated high feasibility, acceptability, and potential clinical relevance in reducing diabetes distress among parents of young children with T1D. While overall treatment effects were modest, use of an attention control condition represents a meaningful advancement in trial rigor for pediatric behavioral interventions. Future adaptations of REDCHiP may enhance its impact, particularly for parents experiencing comorbid depressive symptoms. Clinical Trial: ClinicalTrials.gov NCT3914547
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.